This is H5N1 Global Scan: Avian Flu Worldwide, a Quiet Please production. I’m your host, and today we take a three-minute international lens to examine the impact of H5N1 avian influenza—across continents, economies, research, and response.

Let’s start with the continental breakdown. The Americas have tracked over 5,000 H5N1 outbreaks since 2022, with human cases mostly isolated but deeply concerning. According to the Pan American Health Organization and World Health Organization, 19 countries have reported widespread outbreaks in both birds and mammals—recording 76 human infections and, fortunately, only two deaths in recent years. The virus has infiltrated not just poultry, but also dairy cattle and marine mammals, a new and troubling development. The Centers for Disease Control and Prevention confirms roughly 70 human cases in the U.S. since 2024, most mild, though at least one fatality occurred.

In Europe, outbreaks predominate in western and southern regions. The European Centre for Disease Prevention and Control notes wild birds, especially seabirds, are suffering, though poultry establishments have seen fewer incidents lately. Importantly, no secondary human transmission has occurred in Europe this year, but cross-border wildlife and livestock movement keep officials vigilant.

Across Asia, sporadic but severe outbreaks persist, with human cases still linked to direct poultry exposure—no one-to-one human spread yet confirmed. Countries like Cambodia, Bangladesh, and China have documented multiple cases in 2025 alone. Africa and Oceania face similar risks: outbreaks in birds and mammals threaten biodiversity and food security, and sporadic human infections continue.

Turning to research and global coordination, international networks like the WHO, FAO, and World Organization for Animal Health drive the fight. WHO’s latest reports highlight next-generation vaccines, sensitive diagnostics, and expanded surveillance. There’s an urgent call for national laboratories to share data and for coordinated One Health approaches—bridging human, animal, and environmental health. The FAO urges sustainable improvements in farm biosecurity, wildlife monitoring, and pandemic planning.

Cross-border issues amplify the H5N1 challenge. The virus’s spread via migratory birds transcends customs and quarantine, making country-specific containment difficult. Impacts on international trade are severe: millions of poultry culled, supply chains disrupted, and farmers worldwide losing livelihoods. The USDA and CDC confirm that dairy and poultry restrictions now affect exports from multiple U.S. states and regions in Europe and Asia.

Globally, vaccine development is progressing, but is uneven. Next-generation vaccines targeting circulating clades show promise in trial settings. Efforts in the U.S., Europe, and China aim to protect both birds and humans, but mass deployment is not yet realized, and mismatches between vaccine strains and circulating viruses remain an obstacle.

Comparing national approaches: The U.S. and Europe prioritize rapid detection, culling, and rigorous farm biosecurity. China invests in mass poultry vaccination and proactive surveillance across its vast agricultural sector. Developing nations often rely on regional support and struggle with limited resources, increasing vulnerability.

In summary, H5N1 exemplifies a transboundary health threat demanding international cooperation, scientific innovation, and adaptive policy. As the virus continues to evolve and jump species, the world watches—not just for new scientific breakthroughs but for stronger ties between nations, industries, and public health systems.

Thank you for tuning in. Join us next week for another global scan. This has been a Quiet Please production. For more from me, check out Quiet Please Dot A I.

For more Back to Episodes